30 July 2019

EURO-NMD Patient Advisory Board (PAB) has published a position paper which describes patients’ views on the design of the EURO-NMD registry, its governance, its funding. The paper, which is available to download, formalises patients’ views on the topic ahead of the call for dedicated ERN registries.

Patients’ data registries in Europe in the neuromuscular field followed the spectacular progress of medicine over the past decades.

Due to the high number and heterogeneity of diseases, the variety of collected data types and the various national policies in the domain we observe today a multiplicity of initiatives drawing a highly uneven picture throughout the continent and among diseases.

 

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission


“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit ec.europa.eu/health/ern